Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination

S Guth, U. Theune, Jens Aberle, +2

European Journal of Clinical Investigation

Loss-of-function variants in endothelial lipase are a cause of elevated HDL cholesterol in humans

Andrew C. Edmondson, Robert Brown, Sekar Kathiresan, +17

Journal of Clinical Investigation

Lipase ActivityGenetic EpidemiologyPathologyLoss-of-function VariantsHyperlipidemia +16

Efficacy and safety of once-daily oral semaglutide 25 mg and 50 mg compared with 14 mg in adults with type 2 diabetes (PIONEER PLUS): a multicentre, randomised, phase 3b trial

Vanita R. Aroda, Jens Aberle, Lars Bardtrum, +5

The Lancet

Diabetes ManagementClinical TherapeuticDiabetesPharmacologyClinical Trials +4

Sex hormone and metabolic dysregulations are associated with critical illness in male Covid-19 patients

Maria Schroeder, Berfin Schaumburg, Zacharias Müller, +24

Cardiometabolic RiskSex HormonesImmunologyCovid-19 EpidemiologyImmune System +17

Supervised Obesity Reduction Trial for AF ablation patients: results from the SORT-AF trial

Stephan Willems, Daniel Steven, Jens Aberle, +12

EP Europace

High estradiol and low testosterone levels are associated with critical illness in male but not in female COVID-19 patients: a retrospective cohort study

Maria Schroeder, Berfin Schaumburg, Zacharias Mueller, +22

Emerging Microbes & Infections

Once-Weekly Insulin Icodec With Dosing Guide App Versus Once-Daily Basal Insulin Analogues in Insulin-Naive Type 2 Diabetes (ONWARDS 5)

Harpreet S. Bajaj, Jens Aberle, Melanie J. Davies, +6

Annals of Internal Medicine

The Potential of Semaglutide Once-Weekly in Patients Without Type 2 Diabetes with Weight Regain or Insufficient Weight Loss After Bariatric Surgery—a Retrospective Analysis

Anne Lautenbach, Marie Wernecke, Tobias B. Huber, +5

Obesity Surgery

Preventive medicine of von Hippel–Lindau disease-associated pancreatic neuroendocrine tumors

Alfonso Massimiliano Ferrara, Thera P. Links, Ulrich F. Wellner, +71

Endocrine Related Cancer

A polymorphism, L162V, in the peroxisome proliferator-activated receptor α (PPAR α) gene is associated with lower body mass index in patients with non-insulin-dependent diabetes mellitus

D. Gareth Evans, Jens Aberle, Dorte Wendt, +3

Journal of Molecular Medicine

Metabolic SyndromeMetabolic DisorderPpar αDiabetesGenetic Epidemiology +9